MedPath

Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients.

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000015057
Lead Sponsor
Kitasato University School of Medicine,Endocrinology and Metabolism.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1. severe ketosis, diabetic coma, or before coma 2. before and not long after surgery,or patients with severe trauma 3. alcohol intake's excessive 4. patients who have a fever of 37.0 degrees or more 5. obvious infection 6. severe renal dysfunction or dialysis patients 7. patients with symptoms of urinary retention, difficulty urinating, anuria, or oliguria 8. severe liver dysfunction 9. patients with obvious active malignant tumor 10. women suspected of pregnancy or pregnant 11. patients with a history of use SGLT2 inhibitors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath